Latest Debt Management News

Nufarm Limited’s 2025 AGM revealed a resilient FY24 performance despite industry headwinds, with strong growth in omega-3 canola and strategic cost-saving initiatives setting the stage for future expansion.

Cardiex Limited reported a $2.94 million cash outflow for Q2 FY2025 but bolstered its balance sheet with a $3.25 million placement. The company has begun delivering its CONNEQT Pulse units, signaling a new revenue stream and ongoing R&D investment.

Mustera Property Group progresses design and marketing for its McCabe Street development while maintaining sales momentum at Forbes Residences, alongside a notable executive remuneration update.

Pure Foods Tasmania reports improved revenue and gross profit margin for 2Q25, driven by aggressive cost-cutting and operational efficiencies, while continuing negotiations to lift its ASX trading suspension.

Australis Oil & Gas reported a 3% rise in sales volume for Q4 2024 despite a slight dip in revenue due to lower commodity prices, while actively pursuing partnerships to unlock the full potential of its Tuscaloosa Marine Shale assets.

Ark Mines Ltd reported a significant cash outflow in its December 2024 quarter, prompting plans for a capital raising to support ongoing exploration activities.

Geopacific Resources reported a challenging quarter ending December 2024 with significant cash outflows, prompting a $40 million entitlement offer to secure funding for its Woodlark Project.

Eden Innovations Ltd reports a striking 158% increase in US OptiBlend® sales for Q2 FY25, alongside expanding international traction for its EdenCrete® products and strategic property sales aimed at debt reduction.

Jupiter Energy Limited reported a net operating cash inflow of $776,000 for the December 2024 quarter, maintaining a solid cash position despite heavy exploration expenditures.

MAC Copper Limited delivered a record quarterly copper production of 11,320 tonnes in Q4 2024, alongside a 12% reduction in cash costs to US$1.66/lb, setting the stage for ambitious growth targets by 2026.

SomnoMed Limited reported a solid cash flow performance for Q4 2024, with operating activities generating a net inflow of $1.525 million and ending the quarter with $18.5 million in cash reserves.